Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Hepatitis C | Research article

Core encoding sequences of Hepatitis C virus in Ghanaian blood donors are predominantly mosaics of different genotype 2 strains and cannot distinguish subtypes

Authors: Nicholas Israel Nii-Trebi, Charles Addoquaye Brown, Yaa Difie Osei, William Kwabena Ampofo, Alexander Kwadwo Nyarko

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Distribution of Hepatitis C virus (HCV) genotypes varies significantly worldwide. Genomic diversity between genotypes has implications for treatment, vaccine development and optimal design of HCV diagnostic assays. Molecular characterization of HCV in different geographical areas is therefore very essential for management and public health control of HCV infection. This study investigated the molecular epidemiology and characteristics of HCV genotypes in healthy individuals in Accra, Ghana.

Methods

An experimental study was carried out on blood samples obtained from voluntary blood donors. Two hundred samples were initially screened for HCV antibodies and infection was confirmed by RNA detection through RT-PCR of the 5′-untranslated region (5’UTR). The core gene sequences were analysed for HCV genotype determination by genotype-specific PCR; and then by cloning and direct sequencing followed by phylogenetic analysis. The sequences were further analysed in detail by similarity plotting.

Results

Molecular diagnosis confirmed the presence of HCV RNA in 2 out of 200 (1%) blood donors. Initial genotyping by genotype-specific PCR identified all two infections as subtypes 2a and 2b of genotype 2. Extensive evolutionary and genetic analyses indicated two epidemiological profiles. First, phylogenetic tree topologies clearly showed that, collectively, the core sequences of the Ghanaian HCV isolates belong to a single, distinct genetic group within HCV genotype 2 cluster, with high genetic similarity and rapid sequence variation in a single individual. Second, the sequences are mosaics comprising 2e and other genotype 2 subtype fragments. The analyses underscore a unique and complex HCV genotype 2 core sequence profile of the Ghanaian isolates.

Conclusions

Analysis of HCV core encoding sequences from Ghanaian blood donors in Accra confirmed predominance of genotype 2 HCV among healthy individuals. However, the isolates could not be classified into subtypes, possibly due to their complex sequence pattern that might suggest high mutability of the prevailing genotype. The core region of Ghanaian HCV therefore may not be suitable for distinguishing subtypes. These findings extend those from previous studies and thus underscore the need to search for subtype-informative region of Ghanaian HCV to elucidate the genetic diversity and factors determining outcome of HCV infections in Ghana.
Literature
3.
go back to reference Dubuisson J, Cosset F-L. Virology and cell biology of the hepatitis C virus life cycle: an update. J Hepatol. 2014;61:S3–S13.CrossRef Dubuisson J, Cosset F-L. Virology and cell biology of the hepatitis C virus life cycle: an update. J Hepatol. 2014;61:S3–S13.CrossRef
4.
go back to reference Kurstak E, Kurstak C, Hossain A. The molecular genetics of Hepatitis C virus (HCV) and its use in the diagnosis of HCV infections. In: Kurstak E, editor. New diagnostic procedures. New York: Plenum Medical Book Co; 1994. p. 59–71. Kurstak E, Kurstak C, Hossain A. The molecular genetics of Hepatitis C virus (HCV) and its use in the diagnosis of HCV infections. In: Kurstak E, editor. New diagnostic procedures. New York: Plenum Medical Book Co; 1994. p. 59–71.
5.
go back to reference Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A. 1991;88:3392–6.CrossRef Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A. 1991;88:3392–6.CrossRef
6.
go back to reference Lohmann V. Replication of subgenomic Hepatitis C virus RNAs in a hepatoma cell line. Science. 1999;285:110–3.CrossRef Lohmann V. Replication of subgenomic Hepatitis C virus RNAs in a hepatoma cell line. Science. 1999;285:110–3.CrossRef
7.
go back to reference Bartenschlager R, Lohmann V. Replication of the hepatitis C virus. Best Practice & Research Clin Gastroenterol. 2000;14:241–54.CrossRef Bartenschlager R, Lohmann V. Replication of the hepatitis C virus. Best Practice & Research Clin Gastroenterol. 2000;14:241–54.CrossRef
8.
go back to reference Timm J. Sequence diversity of hepatitis C virus: implications for immune control and therapy. World J Gastroenterol. 2007;13:4808.CrossRef Timm J. Sequence diversity of hepatitis C virus: implications for immune control and therapy. World J Gastroenterol. 2007;13:4808.CrossRef
9.
go back to reference Simmonds P. The origin of hepatitis C virus. Curr Top Microbiol Immunol. 2013;369:1–15.PubMed Simmonds P. The origin of hepatitis C virus. Curr Top Microbiol Immunol. 2013;369:1–15.PubMed
10.
go back to reference Wang W, Zhang X, Xu Y, Weinstock GM, Di Bisceglie AM, Fan X. High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy. PLoS One. 2014;9:e100131.CrossRef Wang W, Zhang X, Xu Y, Weinstock GM, Di Bisceglie AM, Fan X. High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy. PLoS One. 2014;9:e100131.CrossRef
11.
go back to reference Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-a, non-B viral hepatitis genome. Science. 1989;244:359–62.CrossRef Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-a, non-B viral hepatitis genome. Science. 1989;244:359–62.CrossRef
12.
go back to reference Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993;74 (Pt 11:2391–9.CrossRef Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993;74 (Pt 11:2391–9.CrossRef
13.
go back to reference Stuyver L, van Arnhem W, Wyseur A, Hernandez F, Delaporte E, Maertens G. Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes. PNAS. 1994;91:10134–8.CrossRef Stuyver L, van Arnhem W, Wyseur A, Hernandez F, Delaporte E, Maertens G. Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes. PNAS. 1994;91:10134–8.CrossRef
14.
go back to reference Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatol. 2005;42:962–73.CrossRef Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatol. 2005;42:962–73.CrossRef
15.
go back to reference Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatol. 2014;59:318–27.CrossRef Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatol. 2014;59:318–27.CrossRef
16.
go back to reference Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal Hepatol. 2014;61:S45–57.CrossRef Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal Hepatol. 2014;61:S45–57.CrossRef
17.
go back to reference Blach S, Zeuzem S, Manns M, Altraif I, Duberg A-S, Muljono DH, et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2:161–76.CrossRef Blach S, Zeuzem S, Manns M, Altraif I, Duberg A-S, Muljono DH, et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2:161–76.CrossRef
18.
go back to reference Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatol. 2015;61:77–87.CrossRef Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatol. 2015;61:77–87.CrossRef
19.
go back to reference Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis. 2002;2:293–302.CrossRef Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis. 2002;2:293–302.CrossRef
20.
go back to reference Rao VB, Johari N, Du Cros P, Messina J, Ford N, Cooke GS. Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15:819–24.CrossRef Rao VB, Johari N, Du Cros P, Messina J, Ford N, Cooke GS. Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15:819–24.CrossRef
21.
go back to reference Li C, Njouom R, Pépin J, Nakano T, Bennett P, Pybus OG, Lu L. Characterization of full-length hepatitis C virus sequences for subtypes 1e, 1h and 1l, and a novel variant revealed Cameroon as an area in origin for genotype 1. J Gen Virol. 2013;94:1780–90.CrossRef Li C, Njouom R, Pépin J, Nakano T, Bennett P, Pybus OG, Lu L. Characterization of full-length hepatitis C virus sequences for subtypes 1e, 1h and 1l, and a novel variant revealed Cameroon as an area in origin for genotype 1. J Gen Virol. 2013;94:1780–90.CrossRef
22.
go back to reference Candotti D, Temple J, Sarkodie F, Allain J-P. Frequent recovery and broad genotype 2 diversity characterize Hepatitis C virus infection in Ghana, West Africa. J Virol. 2003;77:7914–23.CrossRef Candotti D, Temple J, Sarkodie F, Allain J-P. Frequent recovery and broad genotype 2 diversity characterize Hepatitis C virus infection in Ghana, West Africa. J Virol. 2003;77:7914–23.CrossRef
23.
go back to reference Ndjomou J, Pybus OG, Matz B. Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J Gen Virol. 2003;84:2333–41.CrossRef Ndjomou J, Pybus OG, Matz B. Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J Gen Virol. 2003;84:2333–41.CrossRef
24.
go back to reference Murphy DG, Sablon E, Chamberland J, Fournier E, Dandavino R, Tremblay CL. Hepatitis C virus genotype 7, a new genotype originating from Central Africa. J Clin Microbiol. 2015;53:967–72.CrossRef Murphy DG, Sablon E, Chamberland J, Fournier E, Dandavino R, Tremblay CL. Hepatitis C virus genotype 7, a new genotype originating from Central Africa. J Clin Microbiol. 2015;53:967–72.CrossRef
25.
go back to reference Jeannel D, Fretz C, Traore Y, Kohdjo N, Bigot A, Gamy EP, et al. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J Med Virol. 1998;55:92–7.CrossRef Jeannel D, Fretz C, Traore Y, Kohdjo N, Bigot A, Gamy EP, et al. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J Med Virol. 1998;55:92–7.CrossRef
26.
go back to reference Markov PV, Pepin J, Frost E, Deslandes S, Labbé A-C, Pybus OG. Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa. J Gen Virol. 2009;90:2086–96.CrossRef Markov PV, Pepin J, Frost E, Deslandes S, Labbé A-C, Pybus OG. Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa. J Gen Virol. 2009;90:2086–96.CrossRef
27.
go back to reference Agyeman AA, Ofori-Asenso R, Mprah A, Ashiagbor G. Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis. BMC Infect Dis. 2016;16:391.CrossRef Agyeman AA, Ofori-Asenso R, Mprah A, Ashiagbor G. Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis. BMC Infect Dis. 2016;16:391.CrossRef
28.
go back to reference Wansbrough-Jonesl MH, Frimpong E, Cant B, Harris K, Evans MRW, Teo CG. Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana. Trans R Soc Trop Med Hyg. 1998;92:496–9.CrossRef Wansbrough-Jonesl MH, Frimpong E, Cant B, Harris K, Evans MRW, Teo CG. Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana. Trans R Soc Trop Med Hyg. 1998;92:496–9.CrossRef
29.
go back to reference Purdy MA, Forbi JC, Sue A, Layden JE, Switzer WM, Opare-Sem OK, et al. A re-evaluation of the origin of hepatitis C virus genotype 2 in West Africa. J Gen Virol. 2015;96:2157–64.CrossRef Purdy MA, Forbi JC, Sue A, Layden JE, Switzer WM, Opare-Sem OK, et al. A re-evaluation of the origin of hepatitis C virus genotype 2 in West Africa. J Gen Virol. 2015;96:2157–64.CrossRef
30.
go back to reference Lole KS, Jha JA, Shrotri SP, Tandon BN, Prasad VGM, Arankalle VA. Comparison of Hepatitis C virus genotyping by 5′ noncoding region- and Core-based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India. J Clin Microbiol. 2003;41:5240–4.CrossRef Lole KS, Jha JA, Shrotri SP, Tandon BN, Prasad VGM, Arankalle VA. Comparison of Hepatitis C virus genotyping by 5′ noncoding region- and Core-based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India. J Clin Microbiol. 2003;41:5240–4.CrossRef
31.
go back to reference Cai Q, Zhao Z, Liu Y, Shao X, Gao Z. Comparison of three different HCV genotyping methods: Core, NS5B sequence analysis and line probe assay. International J Mol Med. 2013;31:347–52.CrossRef Cai Q, Zhao Z, Liu Y, Shao X, Gao Z. Comparison of three different HCV genotyping methods: Core, NS5B sequence analysis and line probe assay. International J Mol Med. 2013;31:347–52.CrossRef
32.
go back to reference Konomi N, Yamaguchi M, Naito H, Aiba N, Saito T, Arakawa Y, Abe K. Simultaneous detection of hepatitis B, C, and G viral genomes by multiplex PCR method. Jpn J Infect Dis. 2000;53:70–2.PubMed Konomi N, Yamaguchi M, Naito H, Aiba N, Saito T, Arakawa Y, Abe K. Simultaneous detection of hepatitis B, C, and G viral genomes by multiplex PCR method. Jpn J Infect Dis. 2000;53:70–2.PubMed
33.
go back to reference Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol. 1997;35:201–7.PubMedPubMedCentral Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol. 1997;35:201–7.PubMedPubMedCentral
34.
go back to reference Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucl Acids Symp Ser. 1999:41. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucl Acids Symp Ser. 1999:41.
35.
go back to reference Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870–4.CrossRef Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870–4.CrossRef
36.
go back to reference Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73:152–60.PubMedPubMedCentral Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73:152–60.PubMedPubMedCentral
37.
go back to reference Le Marchand C, Bahia F, Page K, Brites C. Hepatitis C virus infection and spontaneous clearance in HTLV-1 and HIV co-infected patients in Salvador, Bahia, Brazil. Braz J Infect Dis. 2015;19:486–91.CrossRef Le Marchand C, Bahia F, Page K, Brites C. Hepatitis C virus infection and spontaneous clearance in HTLV-1 and HIV co-infected patients in Salvador, Bahia, Brazil. Braz J Infect Dis. 2015;19:486–91.CrossRef
38.
go back to reference Raghuraman S, Park H, Osburn WO, Winkelstein E, Edlin BR, Rehermann B. Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion. J Infect Dis. 2012;205:763–71.CrossRef Raghuraman S, Park H, Osburn WO, Winkelstein E, Edlin BR, Rehermann B. Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion. J Infect Dis. 2012;205:763–71.CrossRef
39.
go back to reference Garten RJ, Lai S-H, Zhang J-B, Liu W, Chen J, Yu X-F. Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from southern China. World J Gastroenterol. 2008;14:1878.CrossRef Garten RJ, Lai S-H, Zhang J-B, Liu W, Chen J, Yu X-F. Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from southern China. World J Gastroenterol. 2008;14:1878.CrossRef
40.
go back to reference Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. PNAS. 1994;91:7792–6.CrossRef Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. PNAS. 1994;91:7792–6.CrossRef
41.
go back to reference Forbi JC, Campo DS, Purdy MA, Dimitrova ZE, Skums P. Xia G-l, et al. intra-host diversity and evolution of hepatitis C virus endemic to Côte d'Ivoire. J Med Virol. 2014;86:765–71.CrossRef Forbi JC, Campo DS, Purdy MA, Dimitrova ZE, Skums P. Xia G-l, et al. intra-host diversity and evolution of hepatitis C virus endemic to Côte d'Ivoire. J Med Virol. 2014;86:765–71.CrossRef
42.
go back to reference Bostan N, Mahmood T. An overview about hepatitis C: a devastating virus. Crit Rev Microbiol. 2010;36:91–133.CrossRef Bostan N, Mahmood T. An overview about hepatitis C: a devastating virus. Crit Rev Microbiol. 2010;36:91–133.CrossRef
43.
go back to reference Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol. 1993;67:7522–32.PubMedPubMedCentral Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol. 1993;67:7522–32.PubMedPubMedCentral
44.
go back to reference Ngandu NK, Seoighe C, Scheffler K. Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission. Virol J. 2009;6:164.CrossRef Ngandu NK, Seoighe C, Scheffler K. Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission. Virol J. 2009;6:164.CrossRef
45.
go back to reference Sanchez-Mazas A, Lemaıˆtre J-F¸o, Currat M. Distinct evolutionary strategies of human leucocyte antigen loci in pathogen-rich environments. Phil Trans R Soc B. 2012;367:830–9.CrossRef Sanchez-Mazas A, Lemaıˆtre J-F¸o, Currat M. Distinct evolutionary strategies of human leucocyte antigen loci in pathogen-rich environments. Phil Trans R Soc B. 2012;367:830–9.CrossRef
46.
go back to reference Spurgin LG, Richardson DS. How pathogens drive genetic diversity: MHC, mechanisms and misunderstandings. Proc Biol Sci. 2010;277:979–88.CrossRef Spurgin LG, Richardson DS. How pathogens drive genetic diversity: MHC, mechanisms and misunderstandings. Proc Biol Sci. 2010;277:979–88.CrossRef
48.
go back to reference Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson PT. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. Journal of Hepatol. 1998;29:207–13.CrossRef Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson PT. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. Journal of Hepatol. 1998;29:207–13.CrossRef
49.
go back to reference Chuang WC-M, Sarkodie F, Brown CJ, Owusu-Ofori S, Brown J, Li C, et al. Protective effect of HLA-B57 on HCV genotype 2 infection in a west African population. J Med Virol. 2007;79:724–33.CrossRef Chuang WC-M, Sarkodie F, Brown CJ, Owusu-Ofori S, Brown J, Li C, et al. Protective effect of HLA-B57 on HCV genotype 2 infection in a west African population. J Med Virol. 2007;79:724–33.CrossRef
50.
go back to reference Gaudieri S, Rauch A, Park LP, Freitas E, Herrmann S, Jeffrey G, et al. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic Hepatitis C virus infection. J Virol. 2006;80:11094–104.CrossRef Gaudieri S, Rauch A, Park LP, Freitas E, Herrmann S, Jeffrey G, et al. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic Hepatitis C virus infection. J Virol. 2006;80:11094–104.CrossRef
51.
go back to reference Huang J, Huang K, Xu R, Wang M, Liao Q, Xiong H, et al. The associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C virus spontaneous clearance are independent of IL28B in the Chinese population. Sci Rep. 2016;6:31485.CrossRef Huang J, Huang K, Xu R, Wang M, Liao Q, Xiong H, et al. The associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C virus spontaneous clearance are independent of IL28B in the Chinese population. Sci Rep. 2016;6:31485.CrossRef
52.
go back to reference Ocal S, Selcuk H, Korkmaz M, Altun R, Yildirim AE, Akbas E. Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patients. Saudi J Gastroenterol. 2014;20:175–81.CrossRef Ocal S, Selcuk H, Korkmaz M, Altun R, Yildirim AE, Akbas E. Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patients. Saudi J Gastroenterol. 2014;20:175–81.CrossRef
53.
go back to reference Bulteel N, Partha Sarathy P, Forrest E, Stanley AJ, Innes H, Mills PR, et al. Factors associated with spontaneous clearance of chronic hepatitis C virus infection. Journal of Hepatol. 2016;65:266–72.CrossRef Bulteel N, Partha Sarathy P, Forrest E, Stanley AJ, Innes H, Mills PR, et al. Factors associated with spontaneous clearance of chronic hepatitis C virus infection. Journal of Hepatol. 2016;65:266–72.CrossRef
54.
go back to reference Cohard M, Liu Q, Perkus M, Gordon E, Brotman B, Prince AM. Hepatitis C virus-specific CTL responses in PBMC from chimpanzees with chronic hepatitis C: determination of CTL and CTL precursor frequencies using a recombinant canarypox virus (ALVAC). J Immunol Methods. 1998;214:121–9.CrossRef Cohard M, Liu Q, Perkus M, Gordon E, Brotman B, Prince AM. Hepatitis C virus-specific CTL responses in PBMC from chimpanzees with chronic hepatitis C: determination of CTL and CTL precursor frequencies using a recombinant canarypox virus (ALVAC). J Immunol Methods. 1998;214:121–9.CrossRef
55.
go back to reference Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, et al. Analysis of a successful immune response against Hepatitis C virus. Immunity. 1999;10:439–49.CrossRef Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, et al. Analysis of a successful immune response against Hepatitis C virus. Immunity. 1999;10:439–49.CrossRef
56.
go back to reference Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med. 1991;325:1325–9.CrossRef Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med. 1991;325:1325–9.CrossRef
57.
go back to reference Courouce AM, Noel L, Barin F, Elghouzzi MH, Lunel F, North ML, Smilovici W. A comparative evaluation of the sensitivity of five anti-Hepatitis C virus immunoblot assays. Vox Sang. 1998;74:217–24.CrossRef Courouce AM, Noel L, Barin F, Elghouzzi MH, Lunel F, North ML, Smilovici W. A comparative evaluation of the sensitivity of five anti-Hepatitis C virus immunoblot assays. Vox Sang. 1998;74:217–24.CrossRef
Metadata
Title
Core encoding sequences of Hepatitis C virus in Ghanaian blood donors are predominantly mosaics of different genotype 2 strains and cannot distinguish subtypes
Authors
Nicholas Israel Nii-Trebi
Charles Addoquaye Brown
Yaa Difie Osei
William Kwabena Ampofo
Alexander Kwadwo Nyarko
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Hepatitis C
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4155-4

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue